Why Genworth Financial Is On Investors’ Radar Today
Genworth Financial (GNW) is back in focus after recent trading left the stock modestly lower over the week but slightly higher over the past month, prompting investors to reassess its insurance driven business mix and valuation.
See our latest analysis for Genworth Financial.
At a share price of US$8.44, Genworth’s recent 1 day share price decline of 2.43% and 7 day share price return of 3.87% contrast with a 1 year total shareholder return of 21.44% and 5 year total shareholder return of 161.30%. This suggests shorter term momentum has cooled while longer term holders have still seen meaningful gains.
If Genworth’s moves have you rethinking where insurance fits in your portfolio, it could be a good time to broaden your search with 19 top founder-led companies.
With Genworth trading at US$8.44 and an intrinsic value estimate that sits close by, the market seems to be treating the stock as fairly valued. This raises the question of whether there is still a buying opportunity or if investors are already pricing in future growth.
Price to Earnings of 14.9x: Is It Justified?
At a last close of $8.44, Genworth Financial is trading on a P/E of 14.9x, which screens as more expensive than both the broader US Insurance industry and its direct peer group.
The P/E ratio compares the share price to earnings per share and is a common shorthand for how much investors are paying for each dollar of current earnings. For an insurer with multiple segments such as mortgage insurance, long term care, and life and annuities, the P/E often reflects how the market weighs near term earnings pressure against the stability of the existing book of business.
For Genworth, the signals are mixed. The company has high quality earnings according to the available checks, yet earnings have declined by 35.3% per year over the past 5 years and were down 28.2% over the past year. With a current net profit margin of 3% compared to 4.2% last year and a low return on equity of 3.6%, a P/E of 14.9x suggests the market is still attaching a relatively full price to those earnings despite the recent track record.
Compared with the US Insurance industry average P/E of 12x and a peer average of 11.5x, Genworth is priced at a clear premium. That gap implies investors are paying more per dollar of earnings than for many insurance peers, even though historical earnings growth has been weak and analyst forecasts are not available to justify that premium.
See what the numbers say about this price — find out in our valuation breakdown.
Result: Price-to-Earnings of 14.9x (OVERVALUED)
However, investors still face risks if Genworth’s earnings remain under pressure or if long term care and annuity obligations weigh more heavily on future profitability.
Find out about the key risks to this Genworth Financial narrative.
Another Angle on Value: Cash Flows Paint a Harsher Picture
If the P/E of 14.9x makes Genworth look slightly pricey, our DCF model goes a step further and flags the shares as clearly overvalued, with the stock at $8.44 versus an estimated future cash flow value of $2.41. That is a wide gap. Which signal would you lean on?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Genworth Financial for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 46 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Next Steps
If this mix of concerns and positives around Genworth leaves you undecided, do not wait around. Instead, consider the company’s 1 key reward and 2 important warning signs to shape your own view.
Looking for more investment ideas?
If Genworth has sharpened your thinking, do not stop here. You owe it to yourself to scan a broader set of opportunities with clear, data driven filters.
- Target potential value opportunities by checking companies our screener flags as 46 high quality undervalued stocks based on their fundamentals and current pricing.
- Prioritise stability with 77 resilient stocks with low risk scores, focusing on businesses that carry lower risk scores so you can build a steadier foundation for your portfolio.
- Hunt for quality names that many investors may be overlooking through our screener containing 24 high quality undiscovered gems, where strong fundamentals meet limited attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com